Kirsi Taimen
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Utility of cranial and cervical vessel magnetic resonance imaging as a diagnostic aid in a patient with suspected giant cell arteritis.
Journal: Scandinavian journal of rheumatology
Published: September 10, 2025
Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation.
Journal: Rheumatology advances in practice
Published: December 02, 2024
Polyarteritis nodosa with abdominal bleeding: imaging with PET/CT and angiography on the same day.
Journal: Rheumatology advances in practice
Published: August 14, 2024
Causes and predictors of death among Finnish patients with systemic sclerosis.
Journal: Scandinavian journal of rheumatology
Published: May 14, 2024
Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study.
Journal: Rheumatology advances in practice
Published: January 20, 2023
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
Journal: Rheumatology international
Published: April 29, 2021
The Delay and Costs of Diagnosing Systemic Vasculitis in a Tertiary-Level Clinic.
Journal: Rheumatology and therapy
Published: October 29, 2020
First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 01, 2020
Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review.
Journal: Rheumatology advances in practice
Published: September 10, 2019
The Clinical Impact of Using 18F-FDG-PET/CT in the Diagnosis of Suspected Vasculitis: The Effect of Dose and Timing of Glucocorticoid Treatment.
Journal: Contrast media & molecular imaging
Published: May 22, 2019
Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.
Journal: PloS one
Published: February 15, 2019
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Journal: Scandinavian journal of rheumatology
Published: April 04, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026